Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Multiple Sclerosis

Free Subscription 08.07.2019 1 Acta Neurol Scand 2 AJNR Am J Neuroradiol 2 Ann Neurol 1 Clin Ther 1 Curr Treat Options Neurol 1 J Neurol 1 J Neurol Sci 1 Neurologia

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Acta Neurol Scand

1. LAAKSO SM, Viitala M, Kuusisto H, Sarasoja T, et al
   Multiple sclerosis in Finland 2018- data from the national register.
   Acta Neurol Scand. 2019 Jul 4. doi: 10.1111/ane.13145.
   PubMed     Text format     Abstract available
   
   

   
   AJNR Am J Neuroradiol

2. FORSLIN Y, Martola J, Bergendal A, Fredrikson S, et al
   Gadolinium Retention in the Brain: An MRI Relaxometry Study of Linear and Macrocyclic Gadolinium-Based Contrast Agents in Multiple Sclerosis.
   AJNR Am J Neuroradiol. 2019 Jun 27. pii: ajnr.A6112. doi: 10.3174/ajnr.A6112.
   PubMed     Text format     Abstract available
   
   
3. LECLER A, El Sanharawi I, El Methni J, Gout O, et al
   Improving Detection of Multiple Sclerosis Lesions in the Posterior Fossa Using an Optimized 3D-FLAIR Sequence at 3T.
   AJNR Am J Neuroradiol. 2019 Jun 27. pii: ajnr.A6107. doi: 10.3174/ajnr.A6107.
   PubMed     Text format     Abstract available
   
   

   
   Ann Neurol

4. CREE BAC, Hauser SL
   Reply to "Silent progression or bout-onset progressive multiple sclerosis?"
   Ann Neurol. 2019 Jun 28. doi: 10.1002/ana.25536.
   PubMed     Text format    
   
   
5. GIL-PEROTIN S, Alcala C, Perez-Miralles FC, Casanova B, et al
   Silent progression or bout-onset progressive multiple sclerosis?
   Ann Neurol. 2019 Jun 28. doi: 10.1002/ana.25537.
   PubMed     Text format    
   
   

   
   Clin Ther

6. KRESA-REAHL K, Repovic P, Robertson D, Okwuokenye M, et al
   Corrigendum to "Effectiveness of Delayed-release Dimethyl Fumarate on Clinical and Patient-Reported Outcomes in Patients With Relapsing Multiple Sclerosis Switching From Glatiramer Acetate: RESPOND, a Prospective Observational Study" [Clinical Therape
   Clin Ther. 2019 Jun 26. pii: S0149-2918(19)30297.
   PubMed     Text format    
   
   

   
   Curr Treat Options Neurol

7. WOOLISCROFT L, Silbermann E, Cameron M, Bourdette D, et al
   Approaches to Remyelination Therapies in Multiple Sclerosis.
   Curr Treat Options Neurol. 2019;21:34.
   PubMed     Text format     Abstract available
   
   

   
   J Neurol

8. BERENGUER-RUIZ L, Gimenez-Martinez J, Palazon-Bru A, Sempere AP, et al
   Relapses and obstetric outcomes in women with multiple sclerosis planning pregnancy.
   J Neurol. 2019 Jun 29. pii: 10.1007/s00415-019-09450.
   PubMed     Text format     Abstract available
   
   

   
   J Neurol Sci

9. MUCCILLI A, Nehme A, Labrie M, Girard M, et al
   Varicella-zoster virus vasculopathy in a multiple sclerosis patient on fingolimod.
   J Neurol Sci. 2019;403:119-121.
   PubMed     Text format    
   
   

   
   Neurologia

10. CIFUENTES-CANOREA P, Nieves-Moreno M, Saenz-Frances F, Santos-Bueso E, et al
    Early and recurrent macular oedema in a patient treated with fingolimod.
    Neurologia. 2019;34:206-207.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: